| 产品名称 | 产品编号 | CAS编号 | 分子式 = 分子量 | 位单 | 联系QQ |
| 苦玄参苷IV; Picfeltarraenin IV | CFN90719 | 184288-35-5 | C47H72O18 = 925.06 | 5mg | QQ客服：215959384 |
| 大豆皂苷 Ba; Soyasaponin Ba | CFN90722 | 114590-20-4 | C48H78O19 = 959.1 | 20mg | QQ客服：2159513211 |
| 丝石竹皂苷元-3-O-β-D-葡萄糖醛酸甲酯; Methyl gypsogenin 3-O-beta-D-glucuronopyranoside | CFN90727 | 96553-02-5 | C37H56O10 = 660.9 | 20mg | QQ客服：1413575084 |
| 瓜子金皂苷XXXI; Polygalasaponin XXXI | CFN90728 | 79103-90-5 | C75H112O36 = 1589.67 | 5mg | QQ客服：2056216494 |
| 苦玄参苷X; Picfeltarraenin X | CFN90730 | 1391826-61-1 | C36H54O11 = 662.81 | 5mg | QQ客服：3257982914 |
| 灵芝酸I; Ganoderic acid I | CFN90740 | 98665-20-4 | C30H44O8 = 532.67 | 5mg | QQ客服：2056216494 |
| 去乙酰基灵芝酸F; Deacetyl ganoderic acid F | CFN90746 | 100665-44-9 | C30H40O8 = 528.6 | 5mg | QQ客服：3257982914 |
| 12β-灵芝酸M; Ganoderic acid M | CFN90747 | 100761-17-9 | C30H42O8 = 530.7 | 10mg | QQ客服：215959384 |
| 灵芝内酯B; Ganolactone B | CFN90748 | 1028449-53-7 | C27H38O6 = 458.6 | 5mg | QQ客服：2056216494 |
| 16-O-Acetylpolyporenic acid C; 16-O-Acetylpolyporenic acid C | CFN96159 | 2535-06-0 | C33H48O5 = 524.7 | 5mg | QQ客服：2159513211 |
| 人参皂苷F4; Ginsenoside F4 | CFN90757 | 181225-33-2 | C42H70O12 = 767.0 | 5mg | QQ客服：3257982914 |
| 马尾柴酸; Barbinervic acid | CFN96162 | 64199-78-6 | C30H48O5 = 488.7 | 5mg | QQ客服：1457312923 |
| 苦苏花皂苷C; Cussosaponin C | CFN90772 | 366814-42-8 | C59H96O25 = 1204 | 5mg | QQ客服：3257982914 |
| 大豆皂苷Ab; Soyasaponin Ab | CFN90773 | 118194-13-1 | C67H104O33 = 1437.6 | 5mg | QQ客服：2159513211 |
| 大豆皂苷Ac; Soyasaponin Ac | CFN90774 | 133882-74-3 | C67H104O32 = 1421.6 | 5mg | QQ客服：1457312923 |
Cell. 2018 Jan 11;172(1-2):249-261.e12. doi: 10.1016/j.cell.2017.12.019.IF=36.216(2019)
Cell Metab. 2020 Mar 3;31(3):534-548.e5. doi: 10.1016/j.cmet.2020.01.002.IF=22.415(2019)
Mol Cell. 2017 Nov 16;68(4):673-685.e6. doi: 10.1016/j.molcel.2017.10.022.IF=14.548(2019)
ACS Nano. 2018 Apr 24;12(4): 3385-3396. doi: 10.1021/acsnano.7b08969.IF=13.903(2019)
Nature Plants. 2016 Dec 22;3: 16206. doi: 10.1038/nplants.2016.205.IF=13.297(2019)
Sci Adv. 2018 Oct 24;4(10): eaat6994. doi: 10.1126/sciadv.aat6994.IF=12.804(2019)